• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Dr Peter Aran on How to Improve Quality Measure Decisions

Video

New approaches for measuring quality need to be developed to get frontline caregivers involved in the early stages of quality measure decisions, said Peter Aran, MD, medical director of population health management at Blue Cross Blue Shield of Oklahoma.

New approaches for measuring quality need to be developed to get frontline caregivers involved in the early stages of quality measure decisions, said Peter Aran, MD, medical director of population health management at Blue Cross Blue Shield of Oklahoma.

Transcript

How can we avoid the physician burden of duplicate quality reporting?

Part of the quadruple aim model that we’re trying to follow is that you ask the practices: what quality metrics or measures do they think we should use? Also, if their own family were being taken care of, what kinds of things would they want to know are being done for their parents, or sisters, or kids? So, having the practices themselves weigh in and help decide which quality measures to use is the better way to go.

Right now, most initiatives, as you know, are figured out or designed by big groups, whether it’s CMS, or whether it’s large insurance companies, or a consortia of academic centers. Then, they’re given to the docs and the docs say take this and run with it. We think another approach, a better approach is you include those docs, the frontline caregivers, earlier upstream and say: help us design this initiative, help us decide which quality measures to use.

Related Videos
Most employees are unprepared to shop for coverage on their own, underscoring the need for stronger decision tools and consumer protections.
Experts warn that ICHRAs could either stabilize or destabilize the individual market, depending on which workers employers shift into these plans.
Aleata Postell, SVP of pharmacy business development, CenterWell Pharmacy
ASCO GI 2026 Recap
Jo Varshney, PhD, DVM, CEO and founder of VeriSIM Life
Dr Marco del Riccio
Bhavana (Tina) Bhatnagar, DO, West Virginia University Cancer Institute at Wheeling Hospital
Dr Debra Patt
Dr Marco del Riccio
Where patients live may shape outcomes in hypertrophic cardiomyopathy, with SDOH linked to higher risks of heart failure and arrhythmias.
© 2026 MJH Life Sciences
AJMC®
All rights reserved.